C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/61 (2006.01) A61K 31/195 (2006.01) A61K 31/44 (2006.01) A61K 51/04 (2006.01) A61P 35/00 (2006.01) C07C 275/16 (2006.01) C07D 213/82 (2006.01) G01N 33/60 (2006.01)
Patent
CA 2732632
Prostate-specific membrane antigen (PSMA) binding compounds having radioisotope substituents are described, as well as chemical precursors thereof. Compounds include pyridine containing compounds, compounds having phenylhydrazine structures, and acylated lysine compounds. The compounds allow ready incorporation of radionuclides for single photon emission computed tomography (SPECT) and positron emission tomography (PET) for imaging, for example, prostate cancer cells and angiogenesis.
Cette invention concerne des composés de liaison à lantigène prostatique spécifique membranaire (PSMA) ayant des substituants radio-isotopes, ainsi que leurs précurseurs chimiques. Linvention concerne aussi des composés comprenant des composés à pyridine, des composés à structures phénylhydrazine et des composés à lysine acylée. Les composés permettent une incorporation facile de radionucléides pour la tomographie d'émission à photon unique (TEPU) et la tomographie d'émission par positons (TEP) pour limagerie, par exemple, les cellules du cancer de la prostate et langiogenèse.
Chen Ying
Mease Ronnie Charles
Pomper Martin Gilbert
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
The Johns Hopkins University
LandOfFree
Psma-binding agents and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Psma-binding agents and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Psma-binding agents and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1977331